UPDATE 2-AstraZeneca's immunotherapy drug wins key lung cancer approval By: Reuters: Company News February 19, 2018 at 03:13 AM EST * Rival BMS, Merck, Roche drugs approved for later disease (Adds shares, analyst reaction) Read More >> Related Stocks: Astrazeneca Plc ADR Bristol-Myers Squibb Merck & Co Rogers Corp